EP2418202
(4-[4-[5-(substituted amino)-pyridin-2-yl]phenyl]-cyclohexyl)-acetic acid derivatives as DGAT inhibitors
:
EP einkaleyfi: Þýðing ekki lögð inn:
28.3.2007:
29.1.2014:
11158211.0
:
27.3.2027
:
(4-[4-[5-(substituted amino)-pyridin-2-yl]phenyl]-cyclohexyl)-acetic acid derivatives as DGAT inhibitors
28.3.2007
29.1.2014
:
Novartis AG:
Lichtstrasse 35, 4056, Basel, CH
:
Serrano-Wu, Michael H:
Belmont, MA, US
:
Kwak, Young-Shin:
Lexington, MA, US
:
Liu, Wenming:
Morris Plains, NJ, US
:
787859 P:
31.3.2006:
US
:
C07D 213/74, C07D 213/75, C07D 213/81, C07D 213/82, C07D 237/20, C07D 239/42, C07D 263/48, C07D 277/42, C07D 401/10, C07D 401/12, C07D 401/14, C07D 405/12, C07D 413/10, C07D 413/12, A61K 31/44, A61K 31/50, A61K 31/53, A61K 31/421, A61K 31/426